I’m not saying people are wrong to be impatient.

I’m not saying people are wrong to be impatient. Of the entities you listed, all have a vested interest in hearing from GNBT about the iikey testing protocol. If GNBT has final and solid results I expect they will share them with BARDA, Canada, et al first. That they haven’t PR’ed results yet doesn’t mean they don’t have them. Nor does it mean that they DO have them. In fact, given that GNBT has no reliable history of successfully developing much of anything, who could blame BARDA if they said ‘okay, these results look pretty good...go back and do it again...and you get the same results the second time we’ll talk.’ The point is that we have nothing but Joe’s publicly expressed enthusiasm for whatever they’re doing. Without publishable data, the most meaningful thing I see are Joe’s statements. I just cannot believe that he’d completely annihilate his own credibility if it turned out later that they had zilch, contrary to his public statements.

I don’t not want them to succeed. However, part of me wishes that they would just go ahead with their GNBT development plan...Excellagen, Altucell etc etc. and stop swinging for the fences. They don’t have big enough bats, and that’s what I really see being expressed in the continuing delays in the vaccine development process. I know, if wishes were horses...but had there been no pandemic we’d likely be revenue positive just on the VA/Excellagen contract alone, and Altucel might already be in human trials.